Emmaus Life Sciences, Inc. (EMMA) › Gross ProfitEmmaus Life Sciences, Inc. (EMMA) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2017: $75.0K2018: $15.47M2019: $21.66M2020: $20.92M2021: $17.30M2022: $15.80M2023: $28.25M2024: $15.45M2025: $11.60M$11.60M2017Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$11.60M-25.0%2024$15.45M-45.3%2023$28.25M+78.8%2022$15.80M-8.6%2021$17.30M-17.3%2020$20.92M-3.4%2019$21.66M+40.0%2018$15.47M+20521.3%2017$75.0K—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share